Singapore: Less Than Three Months Left For Companies To Prepare For New Pharma Rules
Executive Summary
Singapore's efforts to consolidate and streamline the regulatory control of all health products under a single legislation has resulted in the fine-tuning of certain regulatory provisions that drug companies should be aware of.
You may also be interested in...
New Drug Rules On Licensing, Trials, Surveillance Edge Closer In Singapore
Pharmaceutical companies doing business in Singapore are being advised to review the procedures they have in place relating to drug licensing, conducting clinical trials and responding to post-market surveillance in light of proposed legislative changes in the country.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.